India's cumulative Covid-19 vaccination coverage exceeds 1.53 bn

With the administration of over 85 lakh doses of COVID-19 vaccine in the last 24 hours, India's COVID-19 vaccination coverage has exceeded 153.80 crore as per provisional reports till 7 am today.

Coronavirus vaccine, Covid-19 vaccine,
A health worker administers a dose of COVID-19 vaccine to a beneficiary, at Government Polyclinic vaccination centre in Gurugram (Photo: PTI)
ANI General News
1 min read Last Updated : Jan 12 2022 | 12:27 PM IST

With the administration of over 85 lakh doses of COVID-19 vaccine in the last 24 hours, India's COVID-19 vaccination coverage has exceeded 153.80 crore as per provisional reports till 7 am today.

According to the Union Health Ministry, India administered 85,26240 doses, taking the total vaccination coverage to 1,53,80,08,200.

60,405 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 3,46,30,536.

Consequently, India's recovery rate stands at 96.01 per cent.

1,94,720 new cases were reported in the last 24 hours.

India's Active Caseload is presently at 9,55,319. Active cases constitute 2.65 per cent of the country's total positive cases.

The testing capacity across the country continues to be expanded. The last 24 hours saw a total of 17,61,900 tests being conducted. India has so far conducted over 69.52 crore cumulative tests.

While testing capacity has been enhanced across the country, the weekly positivity rate in the country currently stands at 9.82 per cent and the daily positivity rate also reported to be 11.05 per cent.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronCoronavirus VaccineVaccination

First Published: Jan 12 2022 | 12:27 PM IST

Next Story